Firstly, although CCR2 deficiency inhibits the recruitment of inflammatory Ly6C+ macrophages and improves ischemia-induced AKI, it does not alleviate the subsequent CKD, because of the compensatory replenishment of intra-renal Ly6C− macrophages. The gene discussed is CCR2; the disease is ischemia.